Cholera Vaccines Market

Cholera Vaccines Market by Products (Dukoral, Shanchol, Vaxchora, and Others) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1129
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 185
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global cholera vaccines market size is projected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the wide incidence of cholera and growing need for disease prevention vaccines.
 

Cholera Vaccines Market Key Takeaways


Cholera is a type of disease caused by the intake of infected food and water that normally present the bacteria called, Vibrio Cholerae. The infection has a brief incubation time, ranging from a few hours to five days, and is characterized by watery diarrhea in abundance. Cholera is a disease that can be lethal in some cases. The disease manifests itself in both endemic and epidemic forms, and is linked to inadequate hygiene, sanitization, and a lack of safe drinking water. Several vaccines are being gradually developed to aid in the improvement of the immune system and protect from this infectious disease. Many international institutions such as World Health Organization (WHO) have been engaged in numerous activities to develop and employ vaccines to treat infectious diseases. Cholera is one of the infectious diseases that these institutions have been focusing for to prevent it.

With the support of a strategy named "Ending Cholera: A Global Roadmap to 2030," the WHO’s Global Task Force on Cholera Control (GTFCC) have set various programs to reduce the number of fatalities caused by the disease up to 90% during the targeted period. Oral cholera vaccines (OCV) are made available all around the world with the support of GTFCC to assure immunization, particularly in cholera-prone countries of Africa and Asia. Kenya executed the Multi-Sectoral Cholera Prevention and Control Plan (MCPCP) from 2011 to 2016 in collaboration with UNICEF to prevent the disease. Furthermore, in December 2012, the United Nations announced a disease-eradication campaign in Haiti and the Dominican Republic. Immunization coverage is steadily increasing over the world.

According to a WHO report conducted in 2014, between 1997 and 2014, approximately 3,175,206 doses of Dukoral and Shanchol were used in vaccination campaigns around the world. A greater number of doses were used in afflicted areas; yet, vaccines are still underused, despite the fact that 1.4 billion people are at risk. The organization further stated that the establishment of a prequalified vaccine factory increased the global supply of OCV to an estimated 6 million in 2016. According to a WHO article, 1.3 to 4.0 million cases of cholera are reported each year, with 21,000 to 143,000 fatalities worldwide. As per the report, scientists stressed that those people who were lack of access to clean water and basic sanitation are more likely to contract the disease.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing demand for vaccines to be used for disease prevention is expected to fuel the market expansion during the forecast period.
  • Rising awareness about cholera preventive care and availability of certain vaccines to cure the disease are anticipated to boost the market growth in the coming years.
  • Increasing government focus on immunization programs and wide government policies to enhance the healthcare development are expected to spur market expansion in the coming years.
  • Development of novel approaches and practices to new cholera vaccines are projected to push the market growth in the coming years.
  • Longer timeline and stringent FDA guidelines for the drug approval of new drug is anticipated to hamper the market growth.

Scope of the Report

The report on the global cholera vaccines market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Cholera Vaccines Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Dukoral, Shanchol, Vaxchora, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Shantha Biotechnics Private Limited; PaxVax, Inc.; and Valneva SE.

 

Market Segment Insights

Vaxchora segment is expected to grow at a robust pace
Based on products, the cholera vaccines market is segregated into dukoral, shanchol, vaxchora, and others. The dukoral segment is expected to account for a key share of the market in the coming years owing to established stockpile of this OCV by WHO. It is the only vaccine that protects against diarrhea produced by E. coli that produces heat-labile toxin. However, the vaxchora segment is anticipated to expand at a rapid pace during the forecast period owing to its benefits like single-dose immunization and fewer side effects. Vaxchora, a single-dose live attenuated OCV, was approved by the US FDA in June 2016 for the use in individuals aged 18 to 64. According to the Center for Infectious Disease Research and Policy, 90 percent of individuals who are vaccinated produce antibodies, which offer immunity against the disease, as per the study of Vaxchora immunogenicity trials conducted in Australia and the US.
 

Cholera Vaccines Market by Products


North America is expected to dominate the market
On the basis of regions, the cholera vaccines market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific is anticipated to dominate the market during the forecast period owing to rising incidence of cholera and growing importance of immunization. The introduction of Shanchol, an OCV, in 2009 increased demand for immunization in the region. However, the market of North America is expected to exhibit a rapid growth rate in the coming years owing to the introduction of the first and only OCV, Vaxchora, in the US. Furthermore, the number of people from the region travelling to countries where cholera epidemics is occurred often is increasing, which pave more chances to expose to the disease. This leads to raise in the demand for vaccine in the region.
 

Cholera Vaccines Market by Regions

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Cholera Vaccines Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Cholera Vaccines Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Cholera Vaccines Market - Supply Chain
  4.5. Global Cholera Vaccines Market Forecast
     4.5.1. Cholera Vaccines Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Cholera Vaccines Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Cholera Vaccines Market Absolute $ Opportunity
5. Global Cholera Vaccines Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Cholera Vaccines Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Cholera Vaccines Demand Share Forecast, 2019-2026
6. North America Cholera Vaccines Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Cholera Vaccines Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Cholera Vaccines Demand Share Forecast, 2019-2026
7. Latin America Cholera Vaccines Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Cholera Vaccines Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Cholera Vaccines Demand Share Forecast, 2019-2026
8. Europe Cholera Vaccines Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Cholera Vaccines Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Cholera Vaccines Demand Share Forecast, 2019-2026
9. Asia Pacific Cholera Vaccines Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Cholera Vaccines Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Cholera Vaccines Demand Share Forecast, 2019-2026
10. Middle East & Africa Cholera Vaccines Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Cholera Vaccines Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Cholera Vaccines Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Cholera Vaccines Market: Market Share Analysis
  11.2. Cholera Vaccines Distributors and Customers
  11.3. Cholera Vaccines Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Shantha Biotechnics Private Limited
     11.4.2. PaxVax, Inc.
     11.4.3. Valneva SE.

Segments Covered in the Report
The global cholera vaccines market has been segmented on the basis of

Products

  • Dukoral
  • Shanchol
  • Vaxchora
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Shantha Biotechnics Private Limited
  • PaxVax, Inc.
  • Valneva SE.

 

Key players competing in the cholera vaccines market include Shantha Biotechnics Private Limited; PaxVax, Inc.; and Valneva SE. To obtain a solid position in the market, key companies rely on product development, mergers, and acquisitions. Valneva SE, for example, strengthened its product portfolio by acquiring Crucell Sweden AB, partnering all privileges, assets, and licences that linked with Dukoral, a cholera vaccine.
 

Cholera Vaccines Market by Key Players

Buy Report